Effectiveness of Social Robots in Relieving Children's and Adolescents' Anxiety, Pain, Fear and Stress in Perioperative Nursing: A Systematic Review and Meta-Analysis.

J Clin NursJun 20, 2026 (epub)
Clinical ResearchPediatricsAnesthesiologyEmergency MedicineOpen access

Miia Kauppinen, Aku Forsman, Heli Kerimaa et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis evaluated the effectiveness of social robots in alleviating anxiety, pain, fear, and stress in children and adolescents undergoing perioperative care. The analysis included seven studies with 663 participants. It found a significant reduction in post-operative anxiety in children and adolescents, but limited effects on pain, fear, and stress.

Key findings

  • Meta-analysis of two studies showed a significant reduction in post-operative anxiety in children and adolescents.
  • Three studies reported reduced perioperative anxiety, indicating potential benefits of social robots.
  • Interventions had little or no effect on perioperative pain, fear, or stress.

Why it matters

Understanding the role of social robots in managing anxiety during perioperative care can enhance non-pharmacological strategies for pediatric patients, potentially improving their overall experience and outcomes.

Source

PubMed · PMID 42322312Free full text on PubMed Central

Published in J Clin Nurs. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pediatrics

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.